We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$145M
AUM Growth
+$8.65M
Cap. Flow
+$1.37M
Cap. Flow %
0.94%
Top 10 Hldgs %
22.7%
Holding
101
New
2
Increased
42
Reduced
31
Closed
2

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$1.64M
2
BBH icon
VanEck Biotech ETF
BBH
+$519K
3
STT icon
State Street
STT
+$441K
4
MA icon
Mastercard
MA
+$274K
5
OMC icon
Omnicom Group
OMC
+$267K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.93M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$305K
3
WFC icon
Wells Fargo
WFC
+$271K
4
AMGN icon
Amgen
AMGN
+$207K
5
MMM icon
3M
MMM
+$175K

Sector Composition

Rank Sector Weight
1 Industrials 14.79%
2 Technology 13.37%
3 Consumer Staples 10.59%
4 Financials 10.11%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COV
101
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-26,266
Closed -$1.93M
1 2 3 4
5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
LSWM
Lorne Steinberg Wealth Management Montreal, Quebec, Canada $422M AUM 23.86% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return

Boston Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Research & Management held 101 positions worth $145M, up 6.4% from $136M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 4%. Boston Research & Management opened 2 new positions and exited 2, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q2 2014 buy was The Mosaic Company: 33,360 shares worth $1.65M.
  • Boston Research & Management added most to VanEck Biotech ETF in Q2 2014, an estimated $519K increase.
  • Boston Research & Management's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $305K.
  • Boston Research & Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $1.93M.
  • Boston Research & Management's ten largest holdings make up 23% of its $145M portfolio in Q2 2014.
  • Boston Research & Management opened 2 new positions and closed 2 in Q2 2014.
  • Boston Research & Management's portfolio value rose 6.4% quarter-over-quarter to $145M.

Based on Boston Research & Management's 13F filing for Q2 2014, filed 12 Aug 2014.